https://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy
Latin America's Biologics Drug Development market will be USD 377.56 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031. The market is foreseen to reach USD 708.4 million by 2031 due to increasing prevalence of chronic diseases.
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2024 |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2023 | 6.88(USD Billion) |
MARKET SIZE 2024 | 7.42(USD Billion) |
MARKET SIZE 2032 | 13.5(USD Billion) |
SEGMENTS COVERED | Service Type, Therapeutic Area, Client Type, Product Type, Regional |
COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
KEY MARKET DYNAMICS | Rising demand for biologics, Increasing R&D investment, Growing regulatory complexity, Expansion of outsourcing services, Technological advancements in manufacturing |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | WuXi AppTec, Merck KGaA, Lonza, Novartis, Catalent, Recipharm, PPD, Baxter, Snyder Pharmaceuticals, Aenova, Evonik Industries, Resilience, Boehringer Ingelheim, Samsung Biologics, Famar |
MARKET FORECAST PERIOD | 2025 - 2032 |
KEY MARKET OPPORTUNITIES | Increasing demand for personalized medicine, Growth of biologics and biosimilars, Expansion of outsourcing trends, Advancements in biomanufacturing technologies, Rise in healthcare expenditure globally |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.78% (2025 - 2032) |
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Biopharmaceutical Logistics Services is segmented by Application (Pharmaceuticals, Healthcare, Drug manufacturers), Type (Cold chain logistics, Drug distribution, Inventory management) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.transparencymarketresearch.com/privacy-policy.htmlhttps://www.transparencymarketresearch.com/privacy-policy.html
Market Introduction
Attribute | Detail |
---|---|
Driver | Strong Pipeline with Accelerated Approval |
Regional Outlook of Global Biologics Industry
Attribute | Detail |
---|---|
Leading Region | North America |
Global Biologics Market Snapshot
Attribute | Detail |
---|---|
Market Value in 2022 | US$ 515.6 Bn |
Market Forecast Value in 2031 | More than US$ 855.8 Bn |
Growth Rate (CAGR) | 6.9% |
Forecast Period | 2023-2031 |
Historical Data Available for | 2017-2021 |
Quantitative Units | US$ Bn for Value |
Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
Competition Landscape | Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials |
Format | Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope | Available upon request |
Pricing | Available upon request |
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2024 |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2023 | 7.47(USD Billion) |
MARKET SIZE 2024 | 8.63(USD Billion) |
MARKET SIZE 2032 | 27.3(USD Billion) |
SEGMENTS COVERED | Drug Type ,Application ,Technology ,End User ,Service Type ,Regional |
COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
KEY MARKET DYNAMICS | Technological advancements increasing drug development costs rising demand for personalized medicine government initiatives and strategic collaborations |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | Genedata ,Cyclica ,Insilico Medicine ,BioSolveIT ,Accelrys ,Atomwise ,XtalPi ,Molecular Simulations ,BenevolentAI ,Insilicobion ,Certara ,Exscientia ,OpenEye Scientific Software |
MARKET FORECAST PERIOD | 2025 - 2032 |
KEY MARKET OPPORTUNITIES | Growing demand for personalized medicine Advancements in artificial intelligence and machine learning Increasing prevalence of chronic diseases Government support for drug discovery Rising adoption of cloudbased drug discovery platforms |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 15.49% (2025 - 2032) |
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Biologics is segmented by Application (Healthcare, Cancer Treatment, Immunotherapy, Autoimmune Diseases, R&D), Type (Monoclonal Antibodies, Gene Therapy, Vaccines, Recombinant Proteins, Biosimilars) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Contract Biomanufacturing Services is segmented by Application (Pharmaceuticals, Biotech, Healthcare, Food & Beverage, Cosmetics), Type (Cell Line Development, Protein Production, Vaccine Manufacturing, Gene Therapy, Bio-Pharmaceutical Manufacturing) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2024 |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2023 | 28.39(USD Billion) |
MARKET SIZE 2024 | 30.65(USD Billion) |
MARKET SIZE 2032 | 56.6(USD Billion) |
SEGMENTS COVERED | Drug Type ,Route of Administration ,Formulation Type ,Delivery Mechanism ,Therapeutic Application ,Regional |
COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
KEY MARKET DYNAMICS | Rising prevalence of chronic diseases Technological advancements Growing demand for noninvasive drug delivery Increasing focus on patient convenience Surge in RampD investments |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | Scient'x S.A. ,Hemispherx Biopharma, Inc. ,Zogenix, Inc. ,Alnylam Pharmaceuticals, Inc ,AcelRx Pharmaceuticals, Inc. ,PeptonBio ,Enteris BioPharma, Inc ,Orexo AB ,Zealand Pharma A/S ,Cosmo Pharmaceuticals N.V. ,Assertio Holdings, Inc. ,Emisphere Technologies, Inc ,InVivo Therapeutics ,Cadence Pharmaceuticals, Inc. |
MARKET FORECAST PERIOD | 2025 - 2032 |
KEY MARKET OPPORTUNITIES | Controlled release oral drug delivery Personalized medicine Targeted oral drug delivery Nanomedicine in oral drug delivery and Artificial intelligence in oral drug development |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.96% (2025 - 2032) |
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2024 |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2023 | 29.26(USD Billion) |
MARKET SIZE 2024 | 30.75(USD Billion) |
MARKET SIZE 2032 | 45.7(USD Billion) |
SEGMENTS COVERED | Type of Agreement, Therapeutic Area, Partnership Structure, Geographical Focus, Regional |
COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
KEY MARKET DYNAMICS | Regulatory compliance challenges, Intellectual property concerns, Competitive landscape evolution, Emerging market opportunities, Collaborative innovation strategies |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | Roche, Gilead Sciences, Pfizer, Novartis, BristolMyers Squibb, Regeneron Pharmaceuticals, Takeda Pharmaceutical, Biogen, AbbVie, Johnson and Johnson, Merck and Co, GlaxoSmithKline, Amgen, Sanofi, AstraZeneca |
MARKET FORECAST PERIOD | 2025 - 2032 |
KEY MARKET OPPORTUNITIES | Expanding digital health collaborations, Increasing biologics licensing agreements, Growth in personalized medicine partnerships, Rising demand for orphan drug development, Strategic alliances for emerging therapies |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.08% (2025 - 2032) |
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2024 |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2023 | 117.92(USD Billion) |
MARKET SIZE 2024 | 128.36(USD Billion) |
MARKET SIZE 2032 | 252.81(USD Billion) |
SEGMENTS COVERED | Service Type ,Therapeutic Area ,Product Type ,Service Model ,Project Phase ,Regional |
COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
KEY MARKET DYNAMICS | Rising demand for personalized medicine Increased adoption of outsourcing to reduce costs Technological advancements in drug discovery and development Growing prevalence of chronic diseases Expansion of biopharmaceutical industry |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | Catalent ,Alcami ,Recipharm AB ,Merck KGaA ,Lonza ,Boehringer Ingelheim ,CordenPharma International ,Samsung Biologics ,Thermo Fisher Scientific ,Medpace Holdings, Inc. ,Syneos Health ,WuXi AppTec ,Charles River Laboratories International ,Patheon N.V. ,Capsugel |
MARKET FORECAST PERIOD | 2025 - 2032 |
KEY MARKET OPPORTUNITIES | Increased drug development outsourcing Growing demand for biologics Expansion into emerging markets Focus on personalized medicine Technological advancements in drug manufacturing |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.85% (2025 - 2032) |
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2024 |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2023 | 151.45(USD Billion) |
MARKET SIZE 2024 | 163.17(USD Billion) |
MARKET SIZE 2032 | 296.4(USD Billion) |
SEGMENTS COVERED | Therapeutic Area ,Molecule Type ,Service Type ,Scale of Operation ,End-User ,Regional |
COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
KEY MARKET DYNAMICS | Growing Demand for Outsourcing Technological Advancements Increased Focus on Efficiency Regulatory Complexities Rise of Biologics and Specialty Drugs |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | Patheon ,Merck Group ,Thermo Fisher Scientific ,Charles River Laboratories ,Samsung BioLogics ,Agenus ,Akesobio ,Catalent ,Boehringer Ingelheim ,WuXi Advanced Therapies ,Lonza ,FUJIFILM Diosynth Biotechnologies ,Sartorius ,ThermoGenesis Holdings ,BioRad Laboratories |
MARKET FORECAST PERIOD | 2025 - 2032 |
KEY MARKET OPPORTUNITIES | Biotechnological advancements outsourcing advantages personalized medicine expansion technological advancements growing demand for biologics |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.74% (2025 - 2032) |
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2024 |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2023 | 748.27(USD Billion) |
MARKET SIZE 2024 | 824.22(USD Billion) |
MARKET SIZE 2032 | 1786.7(USD Billion) |
SEGMENTS COVERED | Distribution Channel ,Drug Type ,Dosage Form ,Therapeutic Area ,Regional |
COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
KEY MARKET DYNAMICS | Increasing demand for generic drugs Technological advancements Growing prevalence of chronic diseases Stringent regulatory policies |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | Alliance Healthcare ,HD Supply ,Morrisons ,McKesson ,Sanofi ,Cardinal Health ,Owens & Minor ,Roche ,Amerisource ,Novartis ,GlaxoSmithKline ,Medline Industries ,Pfizer |
MARKET FORECAST PERIOD | 2025 - 2032 |
KEY MARKET OPPORTUNITIES | Aging population technological advancements expanding biopharmaceutical sector |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.15% (2025 - 2032) |
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2024 |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2023 | 9.42(USD Billion) |
MARKET SIZE 2024 | 10.38(USD Billion) |
MARKET SIZE 2032 | 22.5(USD Billion) |
SEGMENTS COVERED | Drug Type ,Application ,Composition ,Size ,Regional |
COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
KEY MARKET DYNAMICS | Growing demand for targeted drug delivery Advances in liposome technology Increasing prevalence of chronic diseases Rising focus on personalized medicine Technological advancements in drug delivery systems |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | LipoCure, Inc. ,Marathon Pharmaceuticals LLC ,BioDelivery Sciences International, Inc. ,Pacira Pharmaceuticals, Inc. ,Vanda Pharmaceuticals Inc. ,Teva Pharmaceutical Industries Ltd. ,Sarepta Therapeutics, Inc. ,Intas Pharmaceuticals Ltd. ,Roche Holding AG ,ProCred Pharma LLC ,Greystone Therapeutics, Inc. ,Spectrum Pharmaceuticals, Inc. ,Atossa Therapeutics, Inc. ,Sun Pharmaceutical Industries Ltd. ,EnGeneIC Ltd. |
MARKET FORECAST PERIOD | 2025 - 2032 |
KEY MARKET OPPORTUNITIES | Targeted Drug Delivery Personalized Medicine Biopharmaceutical Advancement Nanomedicine Growth Cancer Treatment Innovations |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.15% (2025 - 2032) |
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Cell Line Development for Biologics is segmented by Application (Biopharmaceuticals, Vaccine Development, Gene Therapy), Type (Mammalian Cell Lines, Insect Cell Lines, CHO Cells) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Biotechnology Services is segmented by Application (Healthcare, Pharmaceuticals, Research, Biotechnology, Diagnostics), Type (Research, Contract manufacturing, Clinical trials, Genetic, Biopharmaceutical) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Plant-based Biologics is segmented by Application (Agriculture, Pharmaceuticals, Biotech) , Type (Protein-based, Enzyme-based, Microbial) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Plant Genomics is segmented by Application (Agriculture, biotech research, food security, climate adaptation, seed production), Type (CRISPR crops, drought-resistant seeds, high-yield varieties, disease-resistant plants, biofortified crops) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Viral Vector Manufacturing CDMO Services is segmented by Application (Gene Therapy, Vaccine Development, Cancer Therapy, Genetic Research, Biopharmaceuticals), Type (AAV, Lentivirus, Adenovirus, Retrovirus, Herpes Simplex Virus) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
https://www.htfmarketinsights.com/privacy-policyhttps://www.htfmarketinsights.com/privacy-policy
Global Microcarrier System is segmented by Application (Biotech, medical research, laboratory), Type (Microcarrier, System, Biotech, Medical, Cell culture) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)
Not seeing a result you expected?
Learn how you can add new datasets to our index.
https://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy
Latin America's Biologics Drug Development market will be USD 377.56 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031. The market is foreseen to reach USD 708.4 million by 2031 due to increasing prevalence of chronic diseases.